Jason A. Steen

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot.

Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot.

Journal: Nature health

Published: August 26, 2026

SRP19 and the protein secretion machinery is a targetable vulnerability in cancers with APC loss.

SRP19 and the protein secretion machinery is a targetable vulnerability in cancers with APC loss.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 10, 2025

Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617.

Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617.

Journal: European urology

Published: January 28, 2025

Prevalence of Germline Pathogenic Variants in Renal Cancer Predisposition Genes in a Population-Based Study of Renal Cell Carcinoma.

Prevalence of Germline Pathogenic Variants in Renal Cancer Predisposition Genes in a Population-Based Study of Renal Cell Carcinoma.

Journal: Cancers

Published: June 18, 2024

Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM.

Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM.

Journal: Breast cancer research : BCR

Published: September 12, 2021

Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing.

Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing.

Journal: NPJ breast cancer

Published: June 13, 2021

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer.

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer.

Journal: Cancers

Published: February 26, 2021

VTRNA2-1: Genetic Variation, Heritable Methylation and Disease Association.

VTRNA2-1: Genetic Variation, Heritable Methylation and Disease Association.

Journal: International journal of molecular sciences

Published: February 10, 2021

Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry.

Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry.

Journal: Cancers

Published: February 09, 2021

Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer.

Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer.

Journal: The Prostate

Published: January 18, 2021

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?

Journal: Genetics research

Published: August 11, 2020

Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.

Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.

Journal: BioTechniques

Published: July 14, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026